NDM-Producing Klebsiella pneumoniae and Multidrug-Resistant Enterococcus faecium Bacteremia: A Report of Two Cases
Abstract
Antimicrobial resistance (AMR) has emerged as a major global healthcare challenge, significantly complicating the management of healthcare-associated infections and limiting available therapeutic options. We present two cases of severe bloodstream infections caused by multidrug-resistant pathogens in patients with prolonged healthcare exposure and multiple comorbidities. The first case involved urinary-source bacteremia caused by NDM (New Delhi metallo-β-lactamase)-producing Klebsiella pneumoniae exhibiting extensive AMR. Despite limited therapeutic options and apparent in vitro resistance, treatment with ceftazidime-avibactam was associated with marked clinical and laboratory improvement, resulting in clinical recovery and hospital discharge. The second case involved urinary-source bacteremia caused by multidrug-resistant Enterococcus faecium in an elderly patient with significant comorbidities and recent broad-spectrum antimicrobial exposure. Despite escalation of antimicrobial therapy and supportive management, the patient experienced progressive clinical deterioration and ultimately died. These cases highlight the substantial therapeutic challenges posed by highly resistant pathogens and emphasize the importance of early microbiological diagnosis, individualized interpretation of antimicrobial susceptibility results, prompt optimization of antimicrobial therapy, and strict infection prevention measures in the management of severe multidrug-resistant infections.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.